Juvenile Myelomonocytic Leukemia (JMML)

Search Trials
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Status:
Completed
Last Changed:
Nov 26, 2021
First Changed:
Apr 22, 2014
Disease(s):
Myeloablative Conditioning
Intervention(s):
CyclophosphamideTBIBusulfanUnmanipulated Bone MarrowTacrolimusMycophenolate mofetil
A Study of PRT1419 Injection in Patients With Relapsed/Refractory Hematologic Malignancies
Status:
Not yet recruiting
Last Changed:
Nov 4, 2021
First Changed:
Nov 4, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
PRT1419
A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Status:
Recruiting
Last Changed:
Jan 28, 2022
First Changed:
Oct 30, 2020
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
JNJ-74856665AZAVEN
Pharmacokinetics, Tolerability and Safety of NEX-18a
Status:
Recruiting
Last Changed:
Sep 17, 2021
First Changed:
Sep 17, 2021
Disease(s):
Myelodysplastic Syndromes (MDS)
Intervention(s):
NEX-18a injectionAzacitidine Injection
Tagraxofusp and Decitabine for the Treatment of Chronic Myelomonocytic Leukemia
Status:
Not yet recruiting
Last Changed:
Nov 24, 2021
First Changed:
Sep 9, 2021
Disease(s):
Chronic Myelomonocytic Leukemia
Intervention(s):
DecitabineTagraxofusp-erzs

Connect. Empower. Inspire.